|
Sulfasalazine Clinical Trials
4 actively recruiting trials across 1 location
No change since May 2026
Also known as: Azulfidine
Pipeline
Phase 3: 2Phase 1/2: 2
Top Sponsors
- University of Zurich1
- University of Nebraska1
- Tanta University1
- Assistance Publique - Hôpitaux de Paris1
Other3 trials
Omaha, Nebraska1 trial
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
University of Nebraska Medical Center
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.